X-linked complicated corpus callosum dysgenesis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1497OMIM:304100Q04.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

X-linked complicated corpus callosum dysgenesis (also known as X-linked complicated agenesis of the corpus callosum or L1 syndrome-related corpus callosum dysgenesis, Orphanet code 1497) is a rare genetic neurodevelopmental disorder characterized by abnormal formation or absence of the corpus callosum — the major bundle of nerve fibers connecting the two hemispheres of the brain. This condition primarily affects the central nervous system and is associated with a range of neurological complications beyond the structural brain abnormality itself. Key clinical features include intellectual disability of variable severity, seizures, spasticity (particularly of the lower limbs), and hydrocephalus. Affected individuals may also present with microcephaly, developmental delay, and difficulties with motor coordination. Because the condition follows an X-linked pattern of inheritance, it predominantly affects males, while carrier females may be asymptomatic or show milder manifestations. Brain imaging typically reveals partial or complete absence of the corpus callosum, often accompanied by other structural brain anomalies such as colpocephaly (dilatation of the occipital horns of the lateral ventricles). There is currently no cure for X-linked complicated corpus callosum dysgenesis. Treatment is supportive and symptomatic, focusing on management of seizures with antiepileptic medications, physical and occupational therapy for motor difficulties, speech therapy for communication challenges, and neurosurgical intervention when hydrocephalus requires shunting. Early intervention programs and multidisciplinary care involving neurologists, developmental pediatricians, and rehabilitation specialists are important for optimizing developmental outcomes. Genetic counseling is recommended for affected families to understand recurrence risks and carrier status.

Clinical phenotype terms— hover any for plain English:

Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for X-linked complicated corpus callosum dysgenesis.

View clinical trials →

No actively recruiting trials found for X-linked complicated corpus callosum dysgenesis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the X-linked complicated corpus callosum dysgenesis community →

No specialists are currently listed for X-linked complicated corpus callosum dysgenesis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to X-linked complicated corpus callosum dysgenesis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open X-linked complicated corpus callosum dysgenesisForum →

No community posts yet. Be the first to share your experience with X-linked complicated corpus callosum dysgenesis.

Start the conversation →

Latest news about X-linked complicated corpus callosum dysgenesis

No recent news articles for X-linked complicated corpus callosum dysgenesis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about X-linked complicated corpus callosum dysgenesis

What is X-linked complicated corpus callosum dysgenesis?

X-linked complicated corpus callosum dysgenesis (also known as X-linked complicated agenesis of the corpus callosum or L1 syndrome-related corpus callosum dysgenesis, Orphanet code 1497) is a rare genetic neurodevelopmental disorder characterized by abnormal formation or absence of the corpus callosum — the major bundle of nerve fibers connecting the two hemispheres of the brain. This condition primarily affects the central nervous system and is associated with a range of neurological complications beyond the structural brain abnormality itself. Key clinical features include intellectual disa

How is X-linked complicated corpus callosum dysgenesis inherited?

X-linked complicated corpus callosum dysgenesis follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does X-linked complicated corpus callosum dysgenesis typically begin?

Typical onset of X-linked complicated corpus callosum dysgenesis is neonatal. Age of onset can vary across affected individuals.